Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Pfizer's prospects for drug fade - The Star-Ledger - NJ.com
 The Star-Ledger - NJ.com | Pfizer's prospects for lung cancer drug fade The Star-Ledger - NJ.com Pfizer said it would end a late-stage study of a promising treatment after it failed to be effective in patients. The company, which is based in ... Pfizer says Sutent breast cancer trials fail Pfizer Says Two Cancer Drugs Fail in Clinical Trials Pfizer Breast Cancer Drug Fails, Halts Lung Cancer Trial |
gene tests not ready: US report - Reuters
 www.worldbulletin.net | Lung cancer gene tests not ready: US report Reuters WASHINGTON (Reuters) - Genetic tests designed to predict how well patients will fare after treatment do very little to guide doctors, ... Gene expression-based prognostic signatures in lung cancer not ready for ... |
gene found - 6minutes
Lung cancer gene found 6minutes US researchers have pinpointed a gene that may help to explain why some non-smokers develop . A quarter of s globally occur in people ... |
Roche Increased Avastin Sales Efforts; Doubles US Force - Wall Street Journal
 Reuters | Roche Increased Avastin Sales Efforts; Doubles US Force Wall Street Journal It is approved in the US and Europe in advanced colorectal cancer, breast cancer, and kidney cancer. It also is approved in the US to treat a ... Don't Bet Against Avastin: Roche's $55000 Cancer Drug Thrives on Bad News Roche aiming to launch 6 new products by end 2014 |
We Are All Fat and Have Cancer - Huffington Post (blog)
We Are All Fat and Have Cancer Huffington Post (blog) For the sake of discussion, I'll refer here to smoking - a habit that clearly contributes to the overwhelming majority of cases and with which ... |
Human Genome drug fails to improve survival - Reuters
 TopNews United States | Human Genome lung cancer drug fails to improve survival Reuters O) said data from a mid-stage trial of its experimental drug showed the drug did not improve progression-free survival or disease response, ... Human Genome Sciences Announces Results of Randomized Phase 2 Trial of ... HGS investors shrug off a mid-stage cancer failure Human Genome Sciences reports disappointing drug trial |
New Way to Treat Inoperable - WebMD
 TopNews United States | New Way to Treat Inoperable Lung Cancer WebMD March 16, 2010 -- An experimental type of highly focused radiation therapy may control inoperable tumors and help people with ... Stereotactic body radiation controlled inoperable lung cancer tumors Stereotactic Body Radiation Therapy May Help Cut Inoperable Lung Cancer Stereotactic Radiation Therapy May Improve Survival With Early Stage ... |
OSI reports European recommendation on Tarceva - BusinessWeek
OSI reports European recommendation on Tarceva BusinessWeek OSI Pharmaceuticals Inc. said Friday a European advisory committee recommended approval of Tarceva as maintenance treatment for patients ... EU drugs body backs extended use for OSI's Tarceva OSI Pharma's Cancer Drug Gets Positive Opinion From CHMP - Update EU panel backs OSI cancer drug |
Abraxis cancer drug meets late-stage trial goal - Reuters
 BigPond News | Abraxis cancer drug meets late-stage trial goal Reuters O) said a late-stage study testing its cancer drug Abraxane in non-small cell met the main trial goal, sending its shares up as much as 36 ... Abraxis Flies On Drug Test Success Abraxis Jumps After Successful Trial of Cancer Drug Abraxis BioScience's Phase III lung cancer trial meets primary endpoint |
gene found in non-smokers - BBC News
 BBC News | Lung cancer gene found in non-smokers BBC News A gene that could help explain why some non-smokers develop has been pinpointed by US researchers. It is hoped that further research into the ... Scientists identify common gene linked to lung cancer in non-smokers Gene find links non-smokers, lung cancer Gene is Linked to Lung Cancer Development in Never Smokers |